SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation

Abstract Background SETD2 is the sole epigenetic factor responsible for catalyzing histone 3, lysine 36, tri-methylation (H3K36me3) in mammals. Its role in regulating cellular processes such as RNA splicing, DNA repair, and spurious transcription initiation underlies its broader tumor suppressor fun...

書誌詳細
出版年:	Genome Biology
主要な著者:	Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, Liguo Wang, Sungho Kim, Xia Zhao, Louis Y. El Khoury, Shafiq Shaikh, Jian Zhong, Jeong-Heon Lee, Jolanta Grembecka, Tomasz Cierpicki, Thai H. Ho, Keith D. Robertson
フォーマット:	論文
言語:	英語
出版事項:	BMC 2025-02-01
主題:	Clear cell renal cell carcinoma (ccRCC) SETD2 Histone 3, lysine 36, tri-methylation (H3K36me3) NSD1 Synthetic lethality (SL) CRISPRi
オンライン･アクセス:	https://doi.org/10.1186/s13059-025-03483-z

類似資料

Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation
著者:: Gerry A. Shipman, 等
出版事項: (2024-10-01)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
著者:: Mengxue Yu, 等
出版事項: (2023-03-01)

Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells
著者:: Saumya M. Sankaran, 等
出版事項: (2017-11-01)

Downregulation of trimethyl transferase SETD2 promotes migration and proliferation of colorectal cancer cell
著者:: CUI Ang, DING Jiazeng, CHEN Haizhen, SHEN Xiaohui, LI Chaofei, LIU Guoliang
出版事項: (2020-03-01)

Prospect of targeting lysine methyltransferase NSD3 for tumor therapy
著者:: Dan Li, 等
出版事項: (2023-08-01)

NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer
著者:: Samantha Tauchmann, 等
出版事項: (2021-08-01)

SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner
著者:: Tianchu Wang, 等
出版事項: (2024-01-01)

Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
著者:: Suwei Wang, 等
出版事項: (2019-03-01)

Histone Methyltransferase SETD2 Is Required for Porcine Early Embryonic Development
著者:: Weini Shao, 等
出版事項: (2022-08-01)

Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
著者:: Shafiq Shaikh, 等
出版事項: (2025-12-01)

SETD2 mutations in primary central nervous system tumors
著者:: Angela N. Viaene, 等
出版事項: (2018-11-01)

SETD2-H3K36ME3: an important bridge between the environment and tumors
著者:: Jiahui He, 等
出版事項: (2023-06-01)

Emerging role of SETD2 in the development and function of immune cells
著者:: Longmin Chen, 等
出版事項: (2025-11-01)

Unveiling FADS3 as a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma through comprehensive RNA and single-cell sequencing
著者:: Zekun Xin, 等
出版事項: (2025-04-01)

Metabolic reprogramming of clear cell renal cell carcinoma
著者:: Haiyan Zhu, 等
出版事項: (2023-06-01)

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
著者:: Hira Javaid, 等
出版事項: (2023-08-01)

SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability
著者:: Manuela Mancini, 等
出版事項: (2025-04-01)

LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress
著者:: Bei Feng, 等
出版事項: (2025-04-01)

NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders
著者:: Suresh Chava, 等
出版事項: (2025-06-01)

Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice
著者:: Shiori Kinoshita, 等
出版事項: (2024-02-01)

APOBEC3C‐mediated NF‐κB activation enhances clear cell renal cell carcinoma progression
著者:: Nora Hase, 等
出版事項: (2025-01-01)

STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma
著者:: Jiyue Wu, 等
出版事項: (2022-11-01)

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration
著者:: Man Jia, 等
出版事項: (2024-11-01)

Developing hypoxia and lactate metabolism-related molecular subtypes and prognostic signature for clear cell renal cell carcinoma through integrating machine learning
著者:: Jinhui Liu, 等
出版事項: (2024-11-01)

The Impact of Image Acquisition Parameters and ComBat Harmonization on the Predictive Performance of Radiomics: A Renal Cell Carcinoma Model
著者:: Abdalla Ibrahim, 等
出版事項: (2022-09-01)

Multilevel Regulation of NF‐κB Signaling by NSD2 Suppresses Kras‐Driven Pancreatic Tumorigenesis
著者:: Wenxin Feng, 等
出版事項: (2024-08-01)

SETD2, an epigenetic tumor suppressor: a focused review on GI tumor
著者:: Ming Hu, 等
出版事項: (2020-01-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
著者:: Youlong Huili, 等
出版事項: (2022-08-01)

Identification of prognostic RNA editing profiles for clear cell renal carcinoma
著者:: Weihong Chen, 等
出版事項: (2024-07-01)

HROB as a novel prognostic biomarker associated with tumor immunity in clear cell renal cell carcinoma: A comprehensive analysis integrating bulk sequencing
著者:: Guixin Ding, 等
出版事項: (2025-04-01)

OASL as a novel prognostic biomarker associated with immune infiltrates in ccRCC
著者:: Zekun Xin, 等
出版事項: (2025-08-01)

FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
著者:: Jiachen Liu, 等
出版事項: (2024-11-01)

Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
著者:: Xiaoxiao Du, 等
出版事項: (2025-04-01)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
著者:: Haitao Niu, 等
出版事項: (2018-07-01)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
著者:: Joachim Albers, 等
出版事項: (2013-04-01)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
著者:: Zuhu Yu, 等
出版事項: (2023-03-01)

SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model, and its catalytic activity is regulated by histone acetylation
著者:: Ricardo J Mack, 等
出版事項: (2025-09-01)

The elevated DERL3 expression indicates poor prognosis in renal clear-cell carcinoma
著者:: Weining Fan, 等
出版事項: (2025-01-01)

KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway
著者:: Hao Deng, 等
出版事項: (2023-12-01)

Knockdown of LMNA inhibits Akt/β-catenin-mediated cell invasion and migration in clear cell renal cell carcinoma cells
著者:: Hui Xin, 等
出版事項: (2023-12-01)